FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
1,872 letters match. Newest first.
-
FoodChongqing Tianrun Food Development Co., Ltd
Chongqing Tianrun Food Development shipped low-acid canned tofu to the U.S. without required canning registration and filed processes.
High risk -
FoodDalai Biotech Company Ltd
FDA says Taiwan’s Dalai Biotech shipped acidified popping boba pearls to the U.S. without required registration or filed scheduled processes.
High risk -
DrugsExcelvision Fareva
Excelvision Fareva, a sterile drug manufacturer, was cited for inadequate mold/black-speck complaint investigations and aseptic contamination controls.
High risk -
DrugsNingbo Riway Industrial Co., Ltd.
Ningbo Riway Industrial, an OTC drug maker in China, was cited for manufacturing-practice failures and unapproved antiseptic wipes.
High risk -
DrugsOSRX, Inc.
OSRX, a Montana compounding facility, made sterile ophthalmic drugs under insanitary conditions with quality and labeling failures.
High risk -
DrugsMentha & Allied Products Private Ltd.
FDA warns Mentha & Allied Products of CGMP failures that leave its APIs adulterated.
High risk -
DrugsShantou S.E.Z. Baojie Industry Co., Ltd.
FDA warns Shantou S.E.Z. Baojie Industry over inadequate CGMP and component testing for OTC drug products, leading to Import Alert 66-40.
High risk -
DrugsTailstorm Health Inc. dba Medivant Health
Tailstorm Health (Medivant Health) sterile compounded drugs had insanitary conditions and current good manufacturing practice failures, prompting a bevacizumab recall.
High risk -
DrugsTaizhou Jingshang Cosmetics Technology Co., Ltd.
FDA warns Taizhou Jingshang Cosmetics Technology over current good manufacturing practice failures in over-the-counter drugs, including missing identity tests for high-risk ingredients.
High risk -
DrugsBioAsia Worldwide Sdn Bhd
FDA warned BioAsia Worldwide over current good manufacturing practice violations for OTC drugs.
High risk -
DrugsNana Barseghian, M.D.
FDA warns clinical investigator Nana Barseghian for enrolling high-body-mass-index subjects in drug trials despite protocol exclusion.
High risk -
FoodCountry Favor Inc.
Country Favor Inc. had no foreign supplier verification program for imported foods, FDA found.
Medium -
DrugsAmazon.com, Inc.
Amazon sold unapproved numbing creams for tattoos and cosmetic procedures, FDA says.
High risk -
DrugsCosco International, Inc.
FDA warned Cosco International over nonprescription drug manufacturing failures and unapproved drug products.
High risk -
DrugsDyno Manufacturing, Inc.
Dyno Manufacturing’s OTC hand sanitizer and antibacterial soap drugs lacked raw-material identity testing and other required manufacturing controls.
High risk -
DrugsBEO Pharma Inc. dba BEO Pharmaceuticals Inc.
FDA cited BEO Pharma for manufacturing quality violations, including missing identity testing of high-risk drug ingredients and releasing a batch before microbial testing.
High risk -
AnimalBailey’s Wellness, LLC dba Bailey’s CBD
Bailey’s CBD markets CBD animal and human products with unapproved drug claims, including products for food-producing animals.
High risk -
AnimalHouse of Alchemy LLC dba CBD Dog Health Hamet & Love LLC dba MycoDog
FDA warned CBD Dog Health and MycoDog their CBD and mushroom pet products are unapproved animal drugs, citing disease-treatment claims online.
High risk -
AnimalHolista LLC dba HolistaPet
FDA warned HolistaPet that its CBD animal products are unapproved new animal drugs and adulterated animal food.
High risk -
DrugsEmpower Clinic Services, LLC dba Empower Pharmacy
FDA warns Empower Pharmacy that insanitary conditions in sterile drug compounding put patients at risk.
High risk -
DrugsProdose, Inc. formerly known as Spirit Pharmaceuticals LLC
Prodose, formerly Spirit Pharmaceuticals, left a cold and flu drug mislisted; FDA calls it misbranded.
Low -
DevicesNoah Medical Corporation
FDA warns Noah Medical of San Jose, CA over quality system failures and missed injury reports for its Galaxy bronchoscopes.
High risk -
DevicesICU Medical
ICU Medical warned for changed Medfusion 4000 and CADD Solis infusion pumps sold without required FDA clearances.
High risk -
DrugsEmpower Clinic Services, LLC dba Empower Pharma
FDA warns Empower Pharma over sterile drug manufacturing deficiencies, labeling, and unapproved compounded drugs after August 2024 inspection.
High risk -
DrugsPMS4PMS, LLC
FDA warns PMS4PMS of Clarence, NY, over CGMP failures and an unapproved menstrual cramp relief cream.
High risk -
DrugsNaturista Store LLC
Naturista Store sold ADVANCE KING, labeled a supplement, containing undeclared dexamethasone, diclofenac, and methocarbamol; FDA calls it an unapproved, misbranded drug.
High risk -
DrugsNubratori, Inc. dba Nubratori Rx
FDA cited Nubratori Rx, a sterile compounding outsourcing facility, for insanitary conditions and manufacturing quality failures that may contaminate its drug products.
High risk -
Drugswww.thesafepills.org
FDA warned www.thesafepills.org for selling unapproved, misbranded tapentadol opioid drugs to U.S. consumers online.
High risk -
DevicesEpiCare Acquisitions, LLC
FDA warns EpiCare Acquisitions over unvalidated EpiCare-Zenith lasers and flawed complaint, corrective-action, record, training, and reporting procedures.
High risk -
DevicesNext Science LLC
FDA warns Next Science that wound gels and irrigation solutions are adulterated and misbranded for uncleared claims and quality failures.
High risk -
DrugsAmerico F. Padilla, M.D.
FDA warns clinical investigator Americo F. Padilla, M.D. over failing to obtain parental consent before enrolling pediatric subjects in drug trials.
High risk -
DrugsBPI Labs, LLC
BPI Labs distributes unapproved Epinephrine Chloride Nasal Solution in a vial FDA says can be mistaken for injectable epinephrine.
High risk -
DrugsYangzhou Sion Commodity Co., Ltd.
FDA warned Yangzhou Sion Commodity over drug manufacturing failures, including untested high-risk ingredients and unreliable lab records.
High risk -
DrugsAnnovex Pharma, Inc.
FDA warns outsourcing facility Annovex Pharma in Lorton, VA, over contaminated sterile drug production and missed FDA reports.
High risk -
DrugsAspen Biopharma Labs Private Limited
FDA warns Aspen Biopharma Labs over current good manufacturing practice failures in active ingredient manufacturing after U.S. recall.
High risk -
DevicesDexcom, Inc.
FDA warned Dexcom over quality-system and design-control failures for G6 and G7 glucose monitors, including an unapproved sensor component change.
High risk -
FoodGonzar Produce, LLC
FDA warns Gonzar Produce over missing foreign supplier verification for imported mangoes and guavas and an unregistered facility.
High risk -
FoodAH USA Group Inc.
AH USA Group, a California food importer, had no Foreign Supplier Verification Program for any food it imports, including dried mushroom and rice vermicelli.
High risk -
DevicesExer Labs, Inc.
Exer Labs marketed its Exer Scan device for AI diagnosis and treatment without FDA approval or clearance and lacked quality procedures.
High risk -
DrugsHangzhou Glamcos Biotech Co., Ltd.
Hangzhou Glamcos Biotech’s OTC antibacterial wipes had CGMP violations and were unapproved and misbranded, FDA says.
High risk -
DrugsAdvanced Pharmaceutical Technology
FDA warns Advanced Pharmaceutical Technology over drug manufacturing quality failures, sterility controls, and unapproved drugs.
High risk -
DrugsNeva Global Grup Sanayi Ic Ve Dis Ticaret Anonim Sirketi
FDA warns Turkish OTC drug maker Neva Global over inadequate component testing, process validation, stability, and quality oversight.
High risk -
DrugsCoLabs Intl. Corp
CoLabs Intl. Corp marketed KLĒNSKIN WASH ON SUNSCREEN, an OTC sunscreen wash, without an FDA-approved application or authorized dosage form.
Medium -
DrugsMehran Michael Bahrami, M.D.
FDA warns clinical investigator Dr. Mehran Michael Bahrami over protocol violations and missing records in investigational drug trials.
High risk -
FoodZacanta LLC
Zacanta LLC lacked an FSVP for fresh beans and carrots imported from Mexico, FDA says.
Medium -
DrugsAspen Pharmacare Holdings Limited
FDA warns Aspen subsidiary over sterile OTC drug manufacturing failures including impurity testing, aseptic practices, data integrity, and environmental monitoring.
High risk -
DevicesRed Oak Instruments, LLC
Red Oak Instruments marketed RU-Fit dynamometer for concussion screening without FDA clearance and had MDR and quality system violations.
High risk -
DrugsRite-Kem Incorporated
FDA warned Rite-Kem over inadequate current good manufacturing practice testing of over-the-counter drugs, including hand sanitizers and antimicrobial products.
High risk -
DrugsVegewax Candleworx Ltd.
FDA warns Vegewax Candleworx over CGMP violations in OTC drug manufacturing, including inadequate component testing and OOS investigations.
High risk -
DrugsPico IV Inc.
FDA warned Pico IV Inc. that its intravenous CBD product Pico IV is an unapproved new drug sold with drug claims.
High risk